Poxel Announces PXL770 Awarded FDA Fast Track Designation for X-linked Adrenoleukodystrophy Apr 11, 2022
Poxel to Report Financial Results for Full Year 2021 and Host Webcast Call on March 22, 2022 Mar 15, 2022
Poxel Reports Financial Update for Cash and Revenue for the Full Year 2021 and Provides Corporate Update Feb 16, 2022
Poxel Announces PXL065 Granted FDA Fast Track Designation for X-linked Adrenoleukodystrophy Feb 16, 2022
Poxel Announces its Participation at Upcoming Investor and Scientific Conferences in January 2022 Dec 14, 2021
Poxel Announces the Formation of its Scientific Advisory Board for Rare Metabolic Diseases Dec 6, 2021
